Cargando…
Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia
BACKGROUND: Evidence based information on the proportion & trend of primary resistance among multidrug resistance (MDR) TB patients is important for designing effective strategies in the control of the disease. METHODS: A retrospective record review of 348 MDR/RR-TB patients treated at All Afric...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062340/ https://www.ncbi.nlm.nih.gov/pubmed/35521633 http://dx.doi.org/10.1016/j.jctube.2022.100315 |
_version_ | 1784698912372686848 |
---|---|
author | Bayissa, Adamu Demissie, Meaza Biru, Mulatu Akalu, Zenebe |
author_facet | Bayissa, Adamu Demissie, Meaza Biru, Mulatu Akalu, Zenebe |
author_sort | Bayissa, Adamu |
collection | PubMed |
description | BACKGROUND: Evidence based information on the proportion & trend of primary resistance among multidrug resistance (MDR) TB patients is important for designing effective strategies in the control of the disease. METHODS: A retrospective record review of 348 MDR/RR-TB patients treated at All African Leprosy Rehabilitation & Training (ALERT) Center from January 2014- December 2018. Categorical variables were compared using Chi-square/Fisher exact test as appropriate. Trend analysis was done using chi-square & linear regression. Logistic regression analysis was done to determine the factors associated with primary MDR/RR TB. Adjusted Odds Ratio (AOR) with 95% CI and p value < 5% were used to report factors associated. RESULT: Proportion of primary resistance among MDR/RR TB patients was 25.9% with 95% CI 21.3–30.3%. The proportion increased form 9.7% in 2014 to 43.4% in 2018 at a yearly increasing rate of 9.27%. Contact history to TB patient & year of diagnosis 2017 and 2018 were significantly associated with primary resistance AOR (95% CI) & p value 4.15(1.75–9.84) p = 0.001, 3.87(1.44–10.39) p = 0.007, 3.43(1.20–9.84) p = 0.022 respectively. CONCLUSION: The study revealed a high proportion of primary resistance among MDR/RR TB during the study period with a linearly increasing fashion thus a need for due attention in the efforts to control MDR TB. |
format | Online Article Text |
id | pubmed-9062340 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-90623402022-05-04 Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia Bayissa, Adamu Demissie, Meaza Biru, Mulatu Akalu, Zenebe J Clin Tuberc Other Mycobact Dis Article BACKGROUND: Evidence based information on the proportion & trend of primary resistance among multidrug resistance (MDR) TB patients is important for designing effective strategies in the control of the disease. METHODS: A retrospective record review of 348 MDR/RR-TB patients treated at All African Leprosy Rehabilitation & Training (ALERT) Center from January 2014- December 2018. Categorical variables were compared using Chi-square/Fisher exact test as appropriate. Trend analysis was done using chi-square & linear regression. Logistic regression analysis was done to determine the factors associated with primary MDR/RR TB. Adjusted Odds Ratio (AOR) with 95% CI and p value < 5% were used to report factors associated. RESULT: Proportion of primary resistance among MDR/RR TB patients was 25.9% with 95% CI 21.3–30.3%. The proportion increased form 9.7% in 2014 to 43.4% in 2018 at a yearly increasing rate of 9.27%. Contact history to TB patient & year of diagnosis 2017 and 2018 were significantly associated with primary resistance AOR (95% CI) & p value 4.15(1.75–9.84) p = 0.001, 3.87(1.44–10.39) p = 0.007, 3.43(1.20–9.84) p = 0.022 respectively. CONCLUSION: The study revealed a high proportion of primary resistance among MDR/RR TB during the study period with a linearly increasing fashion thus a need for due attention in the efforts to control MDR TB. Elsevier 2022-04-25 /pmc/articles/PMC9062340/ /pubmed/35521633 http://dx.doi.org/10.1016/j.jctube.2022.100315 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Bayissa, Adamu Demissie, Meaza Biru, Mulatu Akalu, Zenebe Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia |
title | Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia |
title_full | Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia |
title_fullStr | Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia |
title_full_unstemmed | Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia |
title_short | Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia |
title_sort | proportion and trend of primary resistance among multidrug resistant tuberculosis patients in ethiopia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062340/ https://www.ncbi.nlm.nih.gov/pubmed/35521633 http://dx.doi.org/10.1016/j.jctube.2022.100315 |
work_keys_str_mv | AT bayissaadamu proportionandtrendofprimaryresistanceamongmultidrugresistanttuberculosispatientsinethiopia AT demissiemeaza proportionandtrendofprimaryresistanceamongmultidrugresistanttuberculosispatientsinethiopia AT birumulatu proportionandtrendofprimaryresistanceamongmultidrugresistanttuberculosispatientsinethiopia AT akaluzenebe proportionandtrendofprimaryresistanceamongmultidrugresistanttuberculosispatientsinethiopia |